STOCK TITAN

BioElectronics Corporation - BIEL STOCK NEWS

Welcome to our dedicated page for BioElectronics Corporation news (Ticker: BIEL), a resource for investors and traders seeking the latest updates and insights on BioElectronics Corporation stock.

Bioelectronics Corporation, headquartered in Frederick, Maryland, USA, is an award-winning developer and manufacturer of innovative consumer medical devices designed to treat acute and chronic pain using pioneering pulsed shortwave therapy. These clinically proven and safe devices offer extended duration treatments, superior pulse rates, and lower power levels for convenient home therapy, reducing overall healthcare costs. The company's products, such as ActiPatch® for musculoskeletal pain, Smart Insole™ for foot care, Allay® for menstrual pain, RecoveryRx® for chronic wounds, and postoperative recovery, offer effective and economical solutions for various medical conditions.

Rhea-AI Summary
BioElectronics announces positive results from a study on its FDA-cleared PSWT device for treating osteoarthritis in dogs. 96% of treated dogs showed improvement in passive range of motion and behavioral changes compared to the placebo group. The study, published in Veterinary Medicine & Science, highlights the potential of BioElectronics' technology in enhancing the quality of life for canines with OA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
BioElectronics Corporation announces positive results in a study on treating phantom and residual limb pain with its pulsed shortwave therapy device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
BioElectronics Corporation provides an update on clinical trial progress and potential legal action against MundiPharma. The company discusses ongoing clinical trials, completed studies under peer review, manufacturing improvements, and sales activities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
BioElectronics Corp. (OTC: BIEL) has seen good progress on the research side, with positive results from various clinical studies and a new product design. However, the sales front has been more mixed, with new distributors in some regions but failed talks with a major distributor in Asia and the CIS countries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags

FAQ

What type of medical devices does Bioelectronics Corporation develop?

Bioelectronics Corporation specializes in innovative consumer medical devices that utilize pulsed shortwave therapy to treat acute and chronic pain.

Where is Bioelectronics Corporation headquartered?

Bioelectronics Corporation is headquartered in Frederick, Maryland, USA.

What are the key markets covered by Bioelectronics Corporation's products?

Bioelectronics Corporation's products cover a wide range of markets, including musculoskeletal pain, foot care, menstrual pain, chronic wounds, and postoperative recovery.

What sets Bioelectronics Corporation's devices apart from traditional therapies?

Bioelectronics Corporation's devices offer extended duration treatments, superior pulse rates, and lower power levels for safe home therapy, providing cost-effective solutions for pain management.

What recent achievements has Bioelectronics Corporation made in clinical trials?

Bioelectronics Corporation has conducted successful clinical trials focusing on surgical analgesia, thumb arthritics, and post-amputation pain, showcasing the efficacy of their medical devices in reducing pain and improving quality of life.

How is Bioelectronics Corporation addressing the veterinary medicine market?

Bioelectronics Corporation has developed a unique pulsed shortwave therapy device that has shown promising results in improving the functionality and quality of life for canines diagnosed with osteoarthritis, opening up opportunities in the veterinary medicine market.

What strategic initiatives is Bioelectronics Corporation currently pursuing?

Bioelectronics Corporation is focusing on research, manufacturing processes, and sales to bring its innovative medical devices to the market and generate significant sales.

What future plans does Bioelectronics Corporation have?

Bioelectronics Corporation aims to continue developing its pulsed shortwave therapy technology and establish strong partnerships to expand its product offerings and market reach.

How is Bioelectronics Corporation contributing to reducing healthcare costs?

Bioelectronics Corporation's innovative medical devices offer effective and convenient home therapy solutions, helping to lower the overall cost of care for patients experiencing acute and chronic pain.

How can investors stay informed about Bioelectronics Corporation's progress?

Investors can stay updated on Bioelectronics Corporation's latest news, clinical trials, and achievements by visiting their official website or following their press releases and financial disclosures.

BioElectronics Corporation

OTC:BIEL

BIEL Rankings

BIEL Stock Data

2.47M
0%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
Frederick